Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer

    Not recruiting

    2 1 1 1
    Germany Italy
  • Study of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +3
  • Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Italy Spain
  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    2 1 1
    Investigated drugs:
    Greece Hungary Romania
  • Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium France Germany Italy Poland Spain
  • Study on the Effectiveness and Safety of Bevacizumab, Atezolizumab, and RO7247669 in Patients with Resectable Liver Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria France Germany Spain
  • Study on the Safety and Effectiveness of TheraSphere, Durvalumab, and Tremelimumab for Patients with Liver Cancer (Hepatocellular Carcinoma)

    Not recruiting

    2 1 1 1
    France Italy Spain
  • Study on Hepatocellular Carcinoma: Evaluating Livmoniplimab and Budigalimab for Patients with Advanced or Metastatic Cancer After First-Line Treatment

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Italy Spain
  • Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium France Germany Italy Romania Spain
  • Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France